The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-06

AUTHORS

K.L. Cheung, A.J. Evans, J.F.R. Robertson

ABSTRACT

The role of blood tumour markers is established in the monitoring of response to systemic therapy for patients with metastatic breast cancer assessable by UICC criteria. This paper examines the use of marker measurements (in the form of a previously devised biochemical index score comprising CA15.3, CEA and ESR) in patients with metastatic lesions unassessable for response by UICC criteria. Of 218 patients with metastatic breast cancer treated over a 2-year period in the Nottingham Breast Unit, 43 patients (20%) had unassessable disease and 36 of them with blood marker results available were studied. Eighty-six per cent of patients were biochemically assessable. All patients who achieved biochemical response remained unassessable by UICC criteria. Twenty-two patients progressed initially or subsequently (after an initial biochemical response), either biochemically or by UICC criteria. Biochemical assessment completely paralleled UICC assessment in all eight patients who progressed by both assessments. Biochemical progression occurred ahead of UICC assessment in four of them with a median lead-time of 4.5 months. Biochemical assessment by blood tumour markers is useful in patients with metastatic breast cancer unassessable for response to systemic therapy. These findings need to be confirmed in a larger patient series. More... »

PAGES

273-278

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1017909727019

DOI

http://dx.doi.org/10.1023/a:1017909727019

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043574739

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11561773


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoembryonic Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Databases, Factual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mucin-1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Estrogen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Nottingham City Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412920.c", 
          "name": [
            "Departments of Surgery, City Hospital, Nottingham, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheung", 
        "givenName": "K.L.", 
        "id": "sg:person.016477423232.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016477423232.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nottingham City Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412920.c", 
          "name": [
            "Radiology, City Hospital, Nottingham, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evans", 
        "givenName": "A.J.", 
        "id": "sg:person.011143320627.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011143320627.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nottingham City Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412920.c", 
          "name": [
            "Departments of Surgery, City Hospital, Nottingham, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Robertson", 
        "givenName": "J.F.R.", 
        "id": "sg:person.07764637207.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07764637207.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1997.515", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004720848", 
          "https://doi.org/10.1038/bjc.1997.515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1997.515", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004720848", 
          "https://doi.org/10.1038/bjc.1997.515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(98)00297-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006142703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/clon.2001.9250", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006618236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/clon.2001.9250", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006618236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011360956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/ctrv.1999.0151", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021554127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1990.26", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029956355", 
          "https://doi.org/10.1038/bjc.1990.26"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1990.26", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029956355", 
          "https://doi.org/10.1038/bjc.1990.26"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(97)00178-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030310702"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1991.394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036600884", 
          "https://doi.org/10.1038/bjc.1991.394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1991.394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036600884", 
          "https://doi.org/10.1038/bjc.1991.394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1993.310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038135371", 
          "https://doi.org/10.1038/bjc.1993.310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1993.310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038135371", 
          "https://doi.org/10.1038/bjc.1993.310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0009-9260(98)80168-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043447162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(88)90046-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045342488"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/ejso.1998.0593", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049076197"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.297", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052243168", 
          "https://doi.org/10.1038/bjc.1995.297"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.297", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052243168", 
          "https://doi.org/10.1038/bjc.1995.297"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0960-9776(96)90006-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052815444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/172460080001500310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074706569"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/172460080001500310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074706569"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077564405", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.10.2843", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082983643"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-06", 
    "datePublishedReg": "2001-06-01", 
    "description": "The role of blood tumour markers is established in the monitoring of response to systemic therapy for patients with metastatic breast cancer assessable by UICC criteria. This paper examines the use of marker measurements (in the form of a previously devised biochemical index score comprising CA15.3, CEA and ESR) in patients with metastatic lesions unassessable for response by UICC criteria. Of 218 patients with metastatic breast cancer treated over a 2-year period in the Nottingham Breast Unit, 43 patients (20%) had unassessable disease and 36 of them with blood marker results available were studied. Eighty-six per cent of patients were biochemically assessable. All patients who achieved biochemical response remained unassessable by UICC criteria. Twenty-two patients progressed initially or subsequently (after an initial biochemical response), either biochemically or by UICC criteria. Biochemical assessment completely paralleled UICC assessment in all eight patients who progressed by both assessments. Biochemical progression occurred ahead of UICC assessment in four of them with a median lead-time of 4.5 months. Biochemical assessment by blood tumour markers is useful in patients with metastatic breast cancer unassessable for response to systemic therapy. These findings need to be confirmed in a larger patient series.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1023/a:1017909727019", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1092777", 
        "issn": [
          "0167-6806", 
          "1573-7217"
        ], 
        "name": "Breast Cancer Research and Treatment", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "67"
      }
    ], 
    "name": "The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy", 
    "pagination": "273-278", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "cf8ff12f69b669c29f12f69b9377874193de10673e6fb60339f29952fd293800"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11561773"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8111104"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1017909727019"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043574739"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1017909727019", 
      "https://app.dimensions.ai/details/publication/pub.1043574739"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000507.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1023/A:1017909727019"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1017909727019'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1017909727019'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1017909727019'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1017909727019'


 

This table displays all metadata directly associated to this object as RDF triples.

187 TRIPLES      21 PREDICATES      58 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1017909727019 schema:about N0caa4ba8443a4876b0123f3e5697cf9f
2 N1589afd6e8c44e9fba84877c181927d2
3 N27292314f08b4767b54fab1ecd9cb215
4 N3b506be4e1cb4d4d95133e078a8ebd70
5 N3f526ec9ce93471f87f305f25fb32acf
6 N54a9dabb51bd4546a7bf4e22309a80a5
7 N5f1c8c53bd554e16a66acf88d2b01cd9
8 N64837911003e495689c71af53e351604
9 N95d64176e81b476dbc43d1ae6ea897fc
10 N9eb4e651816b41be983b07d37b9d7c02
11 Nea90c25f250944559a9fd853724d0b9c
12 Nf1a0e95dc6c240c8aa040470c9ac8325
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author N0f93d2a3b705401dbdc625f4f33154ca
16 schema:citation sg:pub.10.1038/bjc.1990.26
17 sg:pub.10.1038/bjc.1991.394
18 sg:pub.10.1038/bjc.1993.310
19 sg:pub.10.1038/bjc.1995.297
20 sg:pub.10.1038/bjc.1997.515
21 https://app.dimensions.ai/details/publication/pub.1077564405
22 https://doi.org/10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f
23 https://doi.org/10.1016/0277-5379(88)90046-6
24 https://doi.org/10.1016/s0009-9260(98)80168-2
25 https://doi.org/10.1016/s0959-8049(97)00178-0
26 https://doi.org/10.1016/s0959-8049(98)00297-4
27 https://doi.org/10.1016/s0960-9776(96)90006-5
28 https://doi.org/10.1053/clon.2001.9250
29 https://doi.org/10.1053/ctrv.1999.0151
30 https://doi.org/10.1053/ejso.1998.0593
31 https://doi.org/10.1177/172460080001500310
32 https://doi.org/10.1200/jco.1996.14.10.2843
33 schema:datePublished 2001-06
34 schema:datePublishedReg 2001-06-01
35 schema:description The role of blood tumour markers is established in the monitoring of response to systemic therapy for patients with metastatic breast cancer assessable by UICC criteria. This paper examines the use of marker measurements (in the form of a previously devised biochemical index score comprising CA15.3, CEA and ESR) in patients with metastatic lesions unassessable for response by UICC criteria. Of 218 patients with metastatic breast cancer treated over a 2-year period in the Nottingham Breast Unit, 43 patients (20%) had unassessable disease and 36 of them with blood marker results available were studied. Eighty-six per cent of patients were biochemically assessable. All patients who achieved biochemical response remained unassessable by UICC criteria. Twenty-two patients progressed initially or subsequently (after an initial biochemical response), either biochemically or by UICC criteria. Biochemical assessment completely paralleled UICC assessment in all eight patients who progressed by both assessments. Biochemical progression occurred ahead of UICC assessment in four of them with a median lead-time of 4.5 months. Biochemical assessment by blood tumour markers is useful in patients with metastatic breast cancer unassessable for response to systemic therapy. These findings need to be confirmed in a larger patient series.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree false
39 schema:isPartOf N10b7079286204515844bd2dd7664d634
40 Ne181196f88ce48e686f919d5725fea05
41 sg:journal.1092777
42 schema:name The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy
43 schema:pagination 273-278
44 schema:productId N10006c38774044b3bafdf74222ad2d32
45 N456419d7a4694d459f6e9ca3cb8164fa
46 N9348537a376340d08625f9b236129200
47 N957941c95f4c4e898f0a9137a4250686
48 Nf998fa1b1c00436ea4c3396bc3cbe738
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043574739
50 https://doi.org/10.1023/a:1017909727019
51 schema:sdDatePublished 2019-04-10T18:19
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher Naec6e67cbd3c4e819c4ff11943ad3d22
54 schema:url http://link.springer.com/10.1023/A:1017909727019
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N0c5900e8332244a98261ffa9a5a22de3 rdf:first sg:person.011143320627.77
59 rdf:rest N568f26b31a144a8e9f7af1a6ad1c9816
60 N0caa4ba8443a4876b0123f3e5697cf9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Disease Progression
62 rdf:type schema:DefinedTerm
63 N0f93d2a3b705401dbdc625f4f33154ca rdf:first sg:person.016477423232.32
64 rdf:rest N0c5900e8332244a98261ffa9a5a22de3
65 N10006c38774044b3bafdf74222ad2d32 schema:name nlm_unique_id
66 schema:value 8111104
67 rdf:type schema:PropertyValue
68 N10b7079286204515844bd2dd7664d634 schema:volumeNumber 67
69 rdf:type schema:PublicationVolume
70 N1589afd6e8c44e9fba84877c181927d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Receptors, Estrogen
72 rdf:type schema:DefinedTerm
73 N27292314f08b4767b54fab1ecd9cb215 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Neoplasm Metastasis
75 rdf:type schema:DefinedTerm
76 N3b506be4e1cb4d4d95133e078a8ebd70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Mucin-1
78 rdf:type schema:DefinedTerm
79 N3f526ec9ce93471f87f305f25fb32acf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Prospective Studies
81 rdf:type schema:DefinedTerm
82 N456419d7a4694d459f6e9ca3cb8164fa schema:name dimensions_id
83 schema:value pub.1043574739
84 rdf:type schema:PropertyValue
85 N54a9dabb51bd4546a7bf4e22309a80a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Treatment Outcome
87 rdf:type schema:DefinedTerm
88 N568f26b31a144a8e9f7af1a6ad1c9816 rdf:first sg:person.07764637207.20
89 rdf:rest rdf:nil
90 N5f1c8c53bd554e16a66acf88d2b01cd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Databases, Factual
92 rdf:type schema:DefinedTerm
93 N64837911003e495689c71af53e351604 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Biomarkers, Tumor
95 rdf:type schema:DefinedTerm
96 N9348537a376340d08625f9b236129200 schema:name readcube_id
97 schema:value cf8ff12f69b669c29f12f69b9377874193de10673e6fb60339f29952fd293800
98 rdf:type schema:PropertyValue
99 N957941c95f4c4e898f0a9137a4250686 schema:name pubmed_id
100 schema:value 11561773
101 rdf:type schema:PropertyValue
102 N95d64176e81b476dbc43d1ae6ea897fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Carcinoembryonic Antigen
104 rdf:type schema:DefinedTerm
105 N9eb4e651816b41be983b07d37b9d7c02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Humans
107 rdf:type schema:DefinedTerm
108 Naec6e67cbd3c4e819c4ff11943ad3d22 schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 Ne181196f88ce48e686f919d5725fea05 schema:issueNumber 3
111 rdf:type schema:PublicationIssue
112 Nea90c25f250944559a9fd853724d0b9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Breast Neoplasms
114 rdf:type schema:DefinedTerm
115 Nf1a0e95dc6c240c8aa040470c9ac8325 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Female
117 rdf:type schema:DefinedTerm
118 Nf998fa1b1c00436ea4c3396bc3cbe738 schema:name doi
119 schema:value 10.1023/a:1017909727019
120 rdf:type schema:PropertyValue
121 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
122 schema:name Medical and Health Sciences
123 rdf:type schema:DefinedTerm
124 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
125 schema:name Oncology and Carcinogenesis
126 rdf:type schema:DefinedTerm
127 sg:journal.1092777 schema:issn 0167-6806
128 1573-7217
129 schema:name Breast Cancer Research and Treatment
130 rdf:type schema:Periodical
131 sg:person.011143320627.77 schema:affiliation https://www.grid.ac/institutes/grid.412920.c
132 schema:familyName Evans
133 schema:givenName A.J.
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011143320627.77
135 rdf:type schema:Person
136 sg:person.016477423232.32 schema:affiliation https://www.grid.ac/institutes/grid.412920.c
137 schema:familyName Cheung
138 schema:givenName K.L.
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016477423232.32
140 rdf:type schema:Person
141 sg:person.07764637207.20 schema:affiliation https://www.grid.ac/institutes/grid.412920.c
142 schema:familyName Robertson
143 schema:givenName J.F.R.
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07764637207.20
145 rdf:type schema:Person
146 sg:pub.10.1038/bjc.1990.26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029956355
147 https://doi.org/10.1038/bjc.1990.26
148 rdf:type schema:CreativeWork
149 sg:pub.10.1038/bjc.1991.394 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036600884
150 https://doi.org/10.1038/bjc.1991.394
151 rdf:type schema:CreativeWork
152 sg:pub.10.1038/bjc.1993.310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038135371
153 https://doi.org/10.1038/bjc.1993.310
154 rdf:type schema:CreativeWork
155 sg:pub.10.1038/bjc.1995.297 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052243168
156 https://doi.org/10.1038/bjc.1995.297
157 rdf:type schema:CreativeWork
158 sg:pub.10.1038/bjc.1997.515 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004720848
159 https://doi.org/10.1038/bjc.1997.515
160 rdf:type schema:CreativeWork
161 https://app.dimensions.ai/details/publication/pub.1077564405 schema:CreativeWork
162 https://doi.org/10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f schema:sameAs https://app.dimensions.ai/details/publication/pub.1011360956
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/0277-5379(88)90046-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045342488
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/s0009-9260(98)80168-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043447162
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/s0959-8049(97)00178-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030310702
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/s0959-8049(98)00297-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006142703
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/s0960-9776(96)90006-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052815444
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1053/clon.2001.9250 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006618236
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1053/ctrv.1999.0151 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021554127
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1053/ejso.1998.0593 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049076197
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1177/172460080001500310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074706569
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1200/jco.1996.14.10.2843 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082983643
183 rdf:type schema:CreativeWork
184 https://www.grid.ac/institutes/grid.412920.c schema:alternateName Nottingham City Hospital
185 schema:name Departments of Surgery, City Hospital, Nottingham, United Kingdom
186 Radiology, City Hospital, Nottingham, United Kingdom
187 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...